Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Read More…
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Phone513-762-6690
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.78 billion
Profitability
Miscellaneous
Employees15,707
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, November 1st. Shareholders of record on Monday, November 11th will be given a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Thursday, November 7th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed announced that its board has initiated a share buyback program on Wednesday, March 7th 2018, which authorizes the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its shares are undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Tuesday, October, 29th. The company reported $3.46 earnings per share for the quarter, topping the Zacks' consensus estimate of $3.31 by $0.15. The firm had revenue of $480.61 million for the quarter, compared to the consensus estimate of $478.89 million. Chemed had a return on equity of 35.06% and a net margin of 11.14%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the company posted $3.07 earnings per share. View Chemed's Earnings History.
When is Chemed's next earnings date?
What price target have analysts set for CHE?
4 brokers have issued 1-year price targets for Chemed's shares. Their forecasts range from $405.00 to $500.00. On average, they expect Chemed's stock price to reach $466.25 in the next year. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
News headlines about CHE stock have been trending somewhat positive recently, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemed earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Chemed.
Are investors shorting Chemed?
Chemed saw a drop in short interest in the month of November. As of November 15th, there was short interest totalling 263,800 shares, a drop of 6.3% from the October 31st total of 281,600 shares. Based on an average trading volume of 110,300 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.7% of the company's shares are sold short. View Chemed's Current Options Chain.
Who are some of Chemed's key competitors?
Some companies that are related to Chemed include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), BioScrip (BIOS), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).
What other stocks do shareholders of Chemed own?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
- Mr. David P. Williams, Exec. VP & CFO (Age 58)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
- Mr. Spencer S. Lee, Exec. VP (Age 63)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 40)
Who are Chemed's major shareholders?
Chemed's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (2.61%), Riverbridge Partners LLC (2.34%), Fisher Asset Management LLC (2.15%), Voya Investment Management LLC (1.17%), TimesSquare Capital Management LLC (0.97%) and Eagle Asset Management Inc. (0.81%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., TimesSquare Capital Management LLC, Gamco Investors INC. ET AL, Copeland Capital Management LLC, Russell Investments Group Ltd., Gabelli Funds LLC, Man Group plc and Assenagon Asset Management S.A.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was acquired by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Carillon Tower Advisers Inc., Squarepoint Ops LLC, Teacher Retirement System of Texas, State of Tennessee Treasury Department, First Trust Advisors LP, Voya Investment Management LLC and Voloridge Investment Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $433.04.
How big of a company is Chemed?
Chemed has a market capitalization of $6.93 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
